Page last updated: 2024-08-23

etoposide and glycolipids

etoposide has been researched along with glycolipids in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (57.14)	29.6817
2010's	1 (14.29)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Asakuma, J; Asano, T; Hayakawa, M; Kuroki, T; Ohba, M; Sumitomo, M	1
Faden, AI; Milstien, S; Movsesyan, V; Murthy, SK; Spiegel, S; Toman, RE	1
Daniel, PT; Dörken, B; Essmann, F; Geilen, CC; Müller, A; Schmelz, K; Schulze-Osthoff, K; Tamm, I; Wieder, T	1
Boustany, RM; Persaud-Sawin, DA	1
Banerjee, S; Bhattacharyya, M; Chakrabarti, S; Jain, CK; Majumder, HK; Majumder, SS; Mondal, NB; Pradhan, BS; Roychoudhury, S	1
Alijas, S; Alonso, MJ; Bouzo, BL; Conejos-Sánchez, I; de la Fuente, M; Jatal, R; Lores, S	1
Advani, AS; Becker, PS; Bixby, DL; DeAngelo, DJ; Feldman, EJ; Jonas, BA; Liesveld, JL; Magnani, JL; Marlton, P; O'Dwyer, ME; Thackray, HM	1

Trials

1 trial(s) available for etoposide and glycolipids

Article	Year
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia. Blood, 2022, 02-24, Volume: 139, Issue:8 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Glycolipids; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Rate	2022

Article

Year

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

Blood, 2022, 02-24, Volume: 139, Issue:8

Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Etoposide; Female; Glycolipids; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Rate

2022

Other Studies

6 other study(ies) available for etoposide and glycolipids

Article	Year
Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. The Journal of clinical investigation, 2002, Volume: 109, Issue:6 Topics: Acetophenones; Antineoplastic Agents, Phytogenic; Apoptosis; Benzopyrans; Caspase Inhibitors; Caspases; Cell Fractionation; Ceramides; Enzyme Inhibitors; Etoposide; Flow Cytometry; Humans; Isoenzymes; Male; Mitochondria; Paclitaxel; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C-delta; Signal Transduction; Sphingomyelins; Tumor Cells, Cultured	2002
Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. Journal of neuroscience research, 2002, May-01, Volume: 68, Issue:3 Topics: Animals; Animals, Newborn; Apoptosis; Brain; Cell Differentiation; Cell Membrane; Cell Survival; Cells, Cultured; Ceramides; Cerebellar Cortex; Cerebral Cortex; Dose-Response Relationship, Drug; Etoposide; Nerve Growth Factors; Neurons; Nucleic Acid Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase; Sphingomyelins; Sphingosine; Stress, Physiological; Up-Regulation	2002
Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Oncogene, 2004, Sep-02, Volume: 23, Issue:40 Topics: Adult; Antineoplastic Agents; Apoptosis; bcl-X Protein; Blotting, Northern; Caspase 8; Caspases; Cell Death; Cell Line, Tumor; Ceramides; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hodgkin Disease; Humans; Intracellular Membranes; Leukemia, Myeloid; Membrane Potentials; Mitochondria; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sphingomyelins; Tumor Necrosis Factor-alpha	2004
Cell death pathways in juvenile Batten disease. Apoptosis : an international journal on programmed cell death, 2005, Volume: 10, Issue:5 Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Autophagy; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Line; Ceramides; Child; Child, Preschool; Enzyme Activation; Etoposide; Golgi Apparatus; Humans; Membrane Glycoproteins; Models, Biological; Molecular Chaperones; Neuronal Ceroid-Lipofuscinoses; Sphingomyelins; Transfection	2005
Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo. Scientific reports, 2015, Jul-20, Volume: 5 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Glycolipids; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53	2015
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer. Scientific reports, 2021, 08-26, Volume: 11, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Delivery Systems; Etoposide; Female; Humans; Mice, Inbred Strains; Mice, Nude; Microscopy, Electron, Scanning; Nanoparticles; Natriuretic Peptides; Neoplasm Metastasis; Particle Size; Receptors, Guanylate Cyclase-Coupled; Sphingomyelins; Tumor Burden; Xenograft Model Antitumor Assays	2021